| Serial Number | 88320219 |
| Word Mark | CHANGING THE WORLD BILLIONS OF CELLS ATA TIME |
| Filing Date | Thursday, February 28, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 29, 2022 |
| Registration Number | 6687289 |
| Registration Date | Tuesday, March 29, 2022 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 18, 2019 |
| Goods and Services | Medical testing for diagnostic or treatment purposes in the field of cancer research; medical diagnostic testing, monitoring and reporting services; medical evaluation of immuno oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; medical monitoring services; medical diagnostic, prognostic and theranostic screening and testing services; collection and preservation of dna for medical purposes; consulting services in the nature of providing medical information; consulting services in the field of healthcare and cancer diagnoses; providing a website featuring health and healthcare information related to cancer, testing and screening; genetic testing for medical purposes; providing information in the field of cancer prevention, screening, diagnosis and treatment for medical diagnostic and treatment purposes; providing genetics assessments in the nature of genetic counseling; genetic testing for medical diagnostic purposes; genomic testing for medical diagnostic purposes; gene analysis and sequencing and dna analysis and sequencing for medical diagnostic purposes and veterinary diagnostics purposes; gene analysis and sequencing and dna analysis and sequencing for use in cancer diagnosis and treatment |
| Goods and Services | Scientific and technological services, namely, scientific research, design, analysis and testing in the field of cancer evolution and new cancer therapies using natural killer cells; industrial research in the field of new pharmaceutical products and new cancer therapies; medical and veterinary research services in the nature of the manipulation of cells within a laboratory or research facility to enable natural killer cells to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services; conducting research and clinical trials for others relating to the use and the engineering of natural killer cells and cancer treatment and therapy; medical and scientific research in the field of cancer treatment and diagnosis; data collection for others for research purposes, namely, the collection, testing and research of patient molecular and genomic data; collection and preservation of human and animal dna for research purposes; providing a website featuring health and healthcare information related to cancer research |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 20, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, March 31, 2020 |
| First Use In Commerce Date | Tuesday, March 31, 2020 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 20, 2019 |
| Primary Code | 044 |
| First Use Anywhere Date | Tuesday, March 31, 2020 |
| First Use In Commerce Date | Tuesday, March 31, 2020 |
| Party Name | KIADIS PHARMA INTELLECTUAL PROPERTY B.V. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 26 - NOT AVAILABLE |
| Address | AMSTERDAM 1105BP NL |
| Party Name | KIADIS PHARMA INTELLECTUAL PROPERTY B.V. |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 26 - NOT AVAILABLE |
| Address | AMSTERDAM 1105BP NL |
| Party Name | CytoSen Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Dallas, TX 75243 |
| Party Name | CytoSen Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Dallas, TX 75243 |
| Event Date | Event Description |
| Monday, March 4, 2019 | NEW APPLICATION ENTERED |
| Wednesday, March 20, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, May 9, 2019 | ASSIGNED TO EXAMINER |
| Friday, May 10, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, June 18, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, May 29, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 18, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 13, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 28, 2020 | SOU EXTENSION 1 FILED |
| Tuesday, January 28, 2020 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, January 28, 2020 | SOU EXTENSION 1 GRANTED |
| Wednesday, August 5, 2020 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, August 5, 2020 | SOU EXTENSION 2 FILED |
| Wednesday, August 5, 2020 | SOU EXTENSION 2 GRANTED |
| Thursday, January 30, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, February 11, 2021 | SOU TEAS EXTENSION RECEIVED |
| Friday, August 7, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, December 23, 2020 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Thursday, February 11, 2021 | SOU EXTENSION 3 GRANTED |
| Thursday, February 11, 2021 | SOU EXTENSION 3 FILED |
| Tuesday, August 3, 2021 | SOU TEAS EXTENSION RECEIVED |
| Saturday, February 13, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, August 3, 2021 | SOU EXTENSION 4 FILED |
| Tuesday, August 3, 2021 | SOU EXTENSION 4 GRANTED |
| Thursday, August 5, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, February 2, 2022 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, February 2, 2022 | SOU EXTENSION 5 FILED |
| Wednesday, February 2, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, February 2, 2022 | USE AMENDMENT FILED |
| Wednesday, February 9, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, February 24, 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Wednesday, February 9, 2022 | SOU EXTENSION 5 GRANTED |
| Wednesday, February 9, 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| Thursday, February 10, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, February 25, 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, March 29, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 17, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, May 17, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, May 17, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, May 17, 2022 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Tuesday, May 17, 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |